Protez Pharmaceuticals Inc.
This article was originally published in Start Up
Executive Summary
The menace of drug resistant bacteria continues to grow. As Big Pharma has exited early-stage antibacterial R&D in recent years, start-ups like Protez Pharmaceuticals have filled the void.